{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.1240.15.3.4003","meta":{"versionId":"3","lastUpdated":"2015-04-10T01:00:01.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"Mathematica EP"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2015-04-10"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1240.15.3.4003","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.3.1240.15.3.4003"}],"version":"20150410","name":"NewOralAnticoagulants","title":"New Oral Anticoagulants","status":"active","experimental":false,"date":"2015-04-10T01:00:01-04:00","publisher":"Mathematica","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: Selected oral anticoagulants (apixaban, dabigatran, rivaroxaban)),(Data Element Scope: Medication),(Inclusion Criteria: ),(Exclusion Criteria: )","compose":{"include":[{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1240.15.2.4005"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1240.15.2.4006"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1240.15.2.4007"]}]},"expansion":{"identifier":"urn:uuid:d9f28550-b87b-476c-b2cd-291ee1a734c5","timestamp":"2023-12-11T01:13:35-05:00","total":16,"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1037044","display":"dabigatran etexilate Oral Capsule"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1037045","display":"dabigatran etexilate 150 MG Oral Capsule"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1037179","display":"dabigatran etexilate 75 MG Oral Capsule"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1114197","display":"rivaroxaban Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1114198","display":"rivaroxaban 10 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1156646","display":"dabigatran etexilate Oral Product"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1156647","display":"dabigatran etexilate Pill"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1157968","display":"rivaroxaban Oral Product"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1157969","display":"rivaroxaban Pill"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1232082","display":"rivaroxaban 15 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1232086","display":"rivaroxaban 20 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1364432","display":"apixaban Oral Product"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1364433","display":"apixaban Pill"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1364434","display":"apixaban Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1364435","display":"apixaban 2.5 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1364445","display":"apixaban 5 MG Oral Tablet"}]}}